ArticleClinical and translational medicine2024

Myelofibrosis predicts deep molecular response 4.5 in chronic myeloid leukaemia patients initially treated with imatinib: An extensive, multicenter and retrospective study to develop a prognostic model.

Tian Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.